EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

DNA methylation status of SHATI / NAT8L promoter in the blood of cigarette smokers

Naotaka Izuo, Hajime Miyanishi, Daisuke Nishizawa, Takuma Fujii, Junko Hasegawa, Naomi Sato, Fumihiko Tanioka, Haruhiko Sugimura, Kazutaka Ikeda iD, Atsumi Nitta iD

Neuropsychopharmacology Reports · 2023

DOI: 10.1002/npr2.12373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2023. Verfasst von Naotaka Izuo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan. Hauptthemen laut MEDLINE: Smoking Cessation, Tobacco Products. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Advenced Animal Model Support (AdAMS) from Japan Society for the Promotion of Science, Japan Society for the Promotion of Science, Kobayashi Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Cigarette smoking is a preventable risk factor for various diseases such as cancer, ischemic stroke, cardiac stroke, and chronic obstructive pulmonary disease. Smoking cessation is of great importance not only for individual smokers but also for social health. Regarding current cessation therapies, the effectiveness of nicotine replacement is limited, and the cost of varenicline medication is considerable. Thus, a method for screening smokers who are responsive to cessation therapy based on the therapeutic effectiveness is required. Peripheral biomarkers reflecting smoking dependence status are necessary to establish a method for achieving effective cessation therapy.

Methods

Methylation status of smokers' blood DNA was evaluated focusing on SHATI/NAT8L, an addiction‐related gene. Eight CpG sites in SHATI/NAT8L were quantified by pyrosequencing.

Results

There was no difference in the methylation status of this gene between smokers ( n = 129) and non‐smokers ( n = 129) at all CpG sites. No correlations between the methylation status of SHATI/NAT8L and indicators of smoking dependence were found.

Conclusions

Although the present study found no significance in the DNA methylation of SHATI/NAT8L among smokers, the exploration of predictable peripheral biomarkers for the effectiveness of smoking cessation therapy is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Smoking CessationTobacco ProductsHumansDNA MethylationSmokersTobacco Use Cessation DevicesBiomarkersAcetyltransferases

Stichwörter der Autor:innen

SHATI/NAT8LDNA methylationcigarette smokerpyrosequencingtobacco dependence screener

Substanzen

BiomarkersNAT8L protein, humanAcetyltransferases

Autor:innen und Institutionen

  • Department of Pharmaceutical Therapy and Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
  • Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
  • Department of Clinical Nursing, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Department of Tumor Pathology, Hamamatsu University School of Medicine, Shizuoka, Japan.
  • Department of Pathology, Iwata City Hospital, Shizuoka, Japan.

ORCID-Profile: Kazutaka Ikeda, Atsumi Nitta

Förderung

  • Advenced Animal Model Support (AdAMS) from Japan Society for the Promotion of Science
  • Japan Society for the Promotion of Science
  • Kobayashi Foundation
  • OTC-Self-Medication Promotion Foundation
  • Smoking Research Foundation

Zitieren

APA

Izuo, N., Miyanishi, H., Nishizawa, D., Fujii, T., Hasegawa, J., Sato, N., Tanioka, F., Sugimura, H., Ikeda, K., & Nitta, A. (2023). DNA methylation status of SHATI / NAT8L promoter in the blood of cigarette smokers. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12373

Vancouver

Izuo N, Miyanishi H, Nishizawa D, Fujii T, Hasegawa J, Sato N, et al. DNA methylation status of SHATI / NAT8L promoter in the blood of cigarette smokers. Neuropsychopharmacology Reports. 2023. doi:10.1002/npr2.12373

BibTeX
@article{Izuo2023,
  author = {Izuo, Naotaka and Miyanishi, Hajime and Nishizawa, Daisuke and Fujii, Takuma and Hasegawa, Junko and Sato, Naomi and Tanioka, Fumihiko and Sugimura, Haruhiko and Ikeda, Kazutaka and Nitta, Atsumi},
  title = {DNA methylation status of SHATI / NAT8L promoter in the blood of cigarette smokers},
  journal = {Neuropsychopharmacology Reports},
  year = {2023},
  doi = {10.1002/npr2.12373}
}
Kostenlos starten →